Mingxia Feng

Daping, 400042, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Metformin promotes anti-tumor immunity in STK11 mutant NSCLC through AXIN1-dependent upregulation of multiple nucleotide metabolites.

Metformin promotes anti-tumor immunity in STK11 mutant NSCLC through AXIN1-dependent upregulation of multiple nucleotide metabolites.

Journal: Oncology research

Published: April 10, 2024

AXIN1/MYC Axis Mediated the Osimertinib Resistance in EGFR Mutant Non-Small Cell Lung Cancer Cells.

AXIN1/MYC Axis Mediated the Osimertinib Resistance in EGFR Mutant Non-Small Cell Lung Cancer Cells.

Journal: The Tohoku journal of experimental medicine

Published: January 17, 2024

Metformin Combining PD-1 Inhibitor Enhanced Anti-Tumor Efficacy in STK11 Mutant Lung Cancer Through AXIN-1-Dependent Inhibition of STING Ubiquitination.

Metformin Combining PD-1 Inhibitor Enhanced Anti-Tumor Efficacy in STK11 Mutant Lung Cancer Through AXIN-1-Dependent Inhibition of STING Ubiquitination.

Journal: Frontiers in molecular biosciences

Published: September 20, 2021

Ibrutinib reverses IL-6-induced osimertinib resistance through inhibition of Laminin α5/FAK signaling.

Ibrutinib reverses IL-6-induced osimertinib resistance through inhibition of Laminin α5/FAK signaling.

Journal: Communications biology

Published: August 20, 2021

Metformin attenuates TGF-β1-induced pulmonary fibrosis through inhibition of transglutaminase 2 and subsequent TGF-β pathways.

Metformin attenuates TGF-β1-induced pulmonary fibrosis through inhibition of transglutaminase 2 and subsequent TGF-β pathways.

Journal: 3 Biotech

Published: February 06, 2020

Effective Treatment of Lung Adenocarcinoma Harboring EGFR-Activating Mutation, T790M, and cis-C797S Triple Mutations by Brigatinib and Cetuximab Combination Therapy.

Effective Treatment of Lung Adenocarcinoma Harboring EGFR-Activating Mutation, T790M, and cis-C797S Triple Mutations by Brigatinib and Cetuximab Combination Therapy.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: November 25, 2019

The diagnostic effect of sequential detection of ADA screening and T-SPOT assay in pleural effusion patients.

The diagnostic effect of sequential detection of ADA screening and T-SPOT assay in pleural effusion patients.

Journal: Artificial cells, nanomedicine, and biotechnology

Published: August 06, 2019

Metformin reduces HGF-induced resistance to alectinib via the inhibition of Gab1.

Metformin reduces HGF-induced resistance to alectinib via the inhibition of Gab1.

Journal: Cell death & disease

Published: July 16, 2019

Effects of bronchial provocation test and bronchial dilation test for the diagnosis of lung diseases.

Effects of bronchial provocation test and bronchial dilation test for the diagnosis of lung diseases.

Journal: Artificial cells, nanomedicine, and biotechnology

Published: April 23, 2019

Protective autophagy decreases osimertinib cytotoxicity through regulation of stem cell-like properties in lung cancer.

Protective autophagy decreases osimertinib cytotoxicity through regulation of stem cell-like properties in lung cancer.

Journal: Cancer letters

Published: November 29, 2018

Retrospective analysis for the false positive diagnosis of PET-CT scan in lung cancer patients.

Retrospective analysis for the false positive diagnosis of PET-CT scan in lung cancer patients.

Journal: Medicine

Published: October 20, 2017

Adjunctive use of prednisolone in the treatment of free-flowing tuberculous pleural effusion: A retrospective cohort study.

Adjunctive use of prednisolone in the treatment of free-flowing tuberculous pleural effusion: A retrospective cohort study.

Journal: Respiratory medicine

Published: September 19, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026